VR-PainCart pilot
- Conditions
- Pain
- Registration Number
- NL-OMON28178
- Lead Sponsor
- Centre for Human Drug Research
- Brief Summary
.A.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 24
• Healthy male subjects aged 18-40 years, inclusive; healthy is defined as no clinically relevant abnormalities identified.
• Able to participate and willing to give written informed consent and to comply with the study restrictions.
• History of symptoms or any significant including (but not limited to) neurological or psychiatric disorder., if assessed by the Principal Investigator as possibly interfering with the study objectives.
• High pain tolerance (80% or higher value for the pain tolerance of the electrical stair test)
• Presence of Virtual Reality Sickness (simulator sickness).
• Smoker of more than 5 cigarettes per day prior to screening or who use tobacco products equivalent to more than 5 cigarettes per day.
• Consume, on average, > 8 units/day of (methyl)-xanthines (e.g. coffee, tea, cola, chocolate) or not able to refrain from use during each stay at the CHDR clinic.
• Have a urine drug screen detecting illicit drug of abuse (morphine, benzodiazepines, cocaine, amphetamine, THC, methamphetamines, MDMA) or a positive alcohol breath test;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method • Electrical Stair: PDT (mA), PTT (mA), Area Under the VAS pain Curve (AUC) (mA*mm).<br>• Electrical Stair (including virtual reality simulation without enhancement): PDT (mA), PTT (mA), Area Under the VAS pain Curve<br>(AUC) (mA*mm).<br>• Electrical Stair (including virtual reality simulation with enhancement): PDT (mA), PTT (mA), Area Under the VAS pain Curve (AUC) (mA*mm).
- Secondary Outcome Measures
Name Time Method Questionnaires on personal characteristics, stress, anxiety and the relationship with electrial pain detection and tolerance thresholds.